Good Look: A Decade Redefining On-Demand Beauty and Building Toward Unicorn Potential

January 8, 2026 12:30 PM

What began as a visionary idea in Mexico has evolved into one of the most ambitious international platforms in the on-demand beauty industry. As it approaches its 10th anniversary in 2026, Good Look-the makeup and hairstyling platform founded by Fer Arriaga-is entering a decisive phase marked by accelerated global expansion, technological scaling, and growing attention from investors and high-profile clients. From its inception, Good Look set...

Read more

Glidewell Opens Applications for the 2026 Guiding Leaders Program

January 8, 2026 12:00 PM

Applications are now open for the 2026 Guiding Leaders program, presented by Glidewell. Welcoming both men and women dentists, this six-month business and leadership development initiative runs from May through October at the Glidewell campus in Irvine, California.Entering its sixth year, this program delivers leadership, growth, and success skills for dentists at every career stage. Through a blend of advanced continuing education, one-on-one...

Read more

The Last Mile of Interoperability Is Still Manual for Behavioral Health and Post‑Acute Care

January 8, 2026 11:15 AM

A new Black Book® flash survey of 290 validated healthcare stakeholders finds that while interoperability headlines often emphasize national frameworks and HL7® FHIR® APIs, the "last mile" of cross-continuum exchange remains stubbornly manual for many organizations, especially across behavioral health, post-acute/long-term care, public health, and community-based organizations (CBOs).Respondents spanning health systems, behavioral health...

Read more

Curiosity Cub (TM) Completes 2025 Tour, Inspiring Future Innovators Through AI

January 8, 2026 11:00 AM

Each year, the Curiosity Cube™, a mobile science lab from MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, embarks on a mission to spark curiosity in STEM among students ages 8-13.In 2025, that mission expanded across three continents: the Curiosity Cube™ completed its seventh North American tour, its fourth European tour, and for the first time, brought hands on science to Southern Africa, stopping in...

Read more

Aqua Sculpt Reviews: Breakthrough Hydro-Nutrient Complex Targets Deep Tissue Hydration and Metabolic Sculpting

January 8, 2026 10:20 AM

SummaryAqua Sculpt has emerged as a significant topic of discussion within the wellness community, drawing attention for its unique approach to cellular hydration and metabolic support.An independent analysis of Aqua Sculpt reveals how its hydration-based formula is making waves. This report examines user complaints, verified reviews, and the science behind this non-stimulant weight loss supplement that is defining a new category in the 2025...

Read more

$50K Michael Jordan Jersey turns into a $4.5M Jackpot Discovery using Real Game Used's Patent Pending AI Technology

January 8, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that its wholly owned subsidiary, Real Game Used (RGU), has identified what is believed to be a 1985-86 Chicago Bulls game-worn road jersey attributed to Michael Jordan through the company's patent-pending AI image-analysis and search technology.To the Company's knowledge, there are no other documented and conclusively photo-matched Michael Jordan jerseys from the 1985-86 NBA season...

Read more

NCQA Names Sarah E. Saxton as Senior Vice President of Quality Services

January 8, 2026 9:05 AM

The National Committee for Quality Assurance (NCQA) today announced the appointment of Sarah E. Saxton, MBA, as Senior Vice President of Quality Services. Saxton brings more than 20 years of experience advancing quality, performance measurement, and large-scale transformation across public and private health systems.In this role, Saxton will lead NCQA's Quality Solutions Group, driving research and implementation efforts that underpin NCQA's...

Read more

Cellev8 Nutrition Welcomes Dr. Guangshuo "Alan" Zhu, MD to Its Board of Directors

January 8, 2026 8:45 AM

Cellev8 Nutrition Inc., (OTCID:CELV) a leader in clinically validated antioxidant and cellular nutrition solutions, proudly announces the appointment of Dr. Guangshuo "Alan" Zhu, MD to its Board of Directors. Dr. Zhu brings decades of groundbreaking experience in cardiovascular medicine, translational research, and antioxidant biochemistry, including pioneering work in Superoxide Dismutase (SOD) - a core ingredient and biological inspiration...

Read more

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

January 8, 2026 8:30 AM

Tivic Health® Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that Management will host a special conference call to further discuss the company's recent acquisition of certain contract development and manufacturing organization (CDMO) assets as announced on December 11, 2025. The call will cover how the acquisition has accelerated key strategic priorities and development and commercialization timelines, as...

Read more

Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection

January 8, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for novel therapeutics while reducing the potential for abuse and overdose, today announced it received a Notice of Allowance from the European Patent Office for the issuance of a patent* for PF8026, a groundbreaking Attention-Deficit/Hyperactivity Disorder (ADHD) therapy. PF8026 is a novel...

Read more

Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy

January 8, 2026 7:00 AM

Ascend Advanced Therapies - ABL Inc. today announced significant appointments to its leadership team.Seiga Ohmine Ph.D. joins as Chief Commercial Officer (CCO)Sharad Dubey CA, CPA joins as Chief Financial Officer (CFO)Patrick Lansky joins as Senior Vice President of Global Business DevelopmentThese appointments reflect Ascend-ABL's focus on strengthening scientific leadership, operational discipline, and customer-centric execution as the company...

Read more

FDA Clears Toetal Solution's Ziptoe Hammertoe System

January 8, 2026 6:30 AM

Toetal Solution, Inc., a Runway Healthcare company, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Ziptoe™ Hammertoe System, an implant designed for proximal interphalangeal joint (PIPJ) arthrodesis in hammertoe correction procedures.The Ziptoe Hammertoe System was developed to deliver consistent fixation while supporting efficient, repeatable surgical workflow. Designed in collaboration with...

Read more

Neurodivergent Empowerment Institute Announces Open Artist Call for Activism-Based Art

January 8, 2026 6:00 AM

The Neurodivergent Empowerment Institute (NEI), part of the Bionic Bloom Wellness Collective family of wellness centers, is issuing an open call for artists creating activism-based art that challenges stigma, centers lived experience, and advocates for equity, autonomy, and human dignity.NEI is seeking artwork that does not remain neutral in the face of injustice. This call welcomes art that speaks directly to systems that impact neurodivergent,...

Read more

Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access

January 8, 2026 1:50 AM

Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announces that its Seattle-based subsidiary, Just - Evotec Biologics, Inc., has received a new grant from the Gates Foundation to enable global access to biotherapeutics utilizing Just - Evotec Biologics' molecular design suite of computational technologies, called "J.MD™".Investment (INV072135) continues the support for selected Gates Foundation grantees to improve the developability...

Read more

Obituary Notice: Peter Schlesinger, 19-Time Emmy Award-Winning Television Producer and Longtime KCOP-TV Program Director

January 7, 2026 9:25 PM

It is with great sadness that we announce the passing of Peter Schlesinger, a noted figure in the television industry who served as Program Director for KCOP-TV from 1971 to 2001 and as a multiple Emmy Award-winning Executive Producer for both national and local television programming. Peter passed away on December 5 in Calabasas. Peter entered the television industry in the late 1950's as a staff director for a local Rockford, Illinois station...

Read more

The Assistance Fund Opens New Program for Myeloproliferative Neoplasms

January 7, 2026 4:40 PM

The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with myeloproliferative neoplasms (MPN). The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles.A rare blood cancer,...

Read more

Citrus Burn Reviews (DOCTOR REVEALS) The Truth Behind the Citrus Fat-Burning Mechanism

January 7, 2026 4:00 PM

For years, metabolic science has chased the wrong problem. Most weight loss supplements attempt to force fat burning with stimulants, yet millions of adults over 35 continue to report stalled results, stubborn fat, and declining energy despite disciplined diets and exercise. What quietly shocked researchers was not another stimulant, but a citrus-derived metabolic mechanism that appeared to re-sensitize thermogenic pathways instead of...

Read more

FDA-Cleared Microbicidal Polymer Kills Deadly, Drug-Resistant Candida Auris Superbug on Contact

January 7, 2026 4:00 PM

Scientists have identified a new ally in the battle against the deadly outbreak of the superbug Candida auris, currently spreading rapidly throughout U.S. Hospitals and becoming even more threatening worldwide. An independent laboratory study shows that Preventogen, an FDA-cleared microbicidal liquid polymer, kills 99.99 percent of the C. auris fungus on contact. The triple-action liquid product, which eliminates drug-resistant bacteria, viruses...

Read more

Emerging Growth Research Maintains Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Strategic U.S. Market Entry

January 7, 2026 12:20 PM

Emerging Growth Research today announced the release of its Flash Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), maintaining a Buy-Extended rating and its 12-month price target of $9.00, representing significant upside from the Company's closing price of $4.44 on January 6, 2026.The Flash Report highlights SBC's major milestone entry into the United States medical aesthetics market through a strategic minority equity investment and...

Read more

TRNR Provides Shareholder Update on Sportstech Process & Operating Strategy

January 7, 2026 10:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, today announced that it has published a shareholder letter updating investors with respect to the Sportstech loan and acquisition process and providing additional context about its improved operating scale and near-term plans.Shareholders may also visit www.interactivestrength.com and sign...

Read more